Main competitors
Add to a list
Analyst Opinion 4m Target Price Revision 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Average Target P. Ecart obj. / dr Nbr of analysts
50.33 +80.73%9
1,155.01 +0.89%25
509.82 +8.22%29
510.75 +2.38%15
99.07 +8.81%18
272.96 +41.20%21
2,409.94 +29.95%17
58.36 +48.08%18
145.00 +25.78%7
193.59 +51.61%20
87.50 +21.83%16
168.72 +39.85%25
18.79 +28.29%3
82.93 +64.68%19
1,015.14 +18.32%7
59.10 -0.24%10
27.52 +7.89%21
856.00 +25.33%4
164.73 +56.54%13
Average 415.01 +29.48% 16
Weighted average by Cap. 636.45 +15.18% 21
Bio Therapeutic Drugs
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW